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Serotonergic neurons project to virtually all regions of the central nervous system and
are consequently involved in many critical physiological functions such as mood, sexual
behavior, feeding, sleep/wake cycle, memory, cognition, blood pressure regulation,
breathing, and reproductive success. Therefore, serotonin release and serotonergic
neuronal activity have to be precisely controlled and modulated by interacting brain circuits
to adapt to speciﬁc emotional and environmental states. We will review the current
knowledge about G protein-coupled receptors and ion channels involved in the regulation of
serotonergic system, how their regulation ismodulating the intrinsic activity of serotonergic
neurons and its transmitter release and will discuss the latest methods for controlling the
modulation of serotonin release and intracellular signaling in serotonergic neurons in vitro
and in vivo.
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INTRODUCTION
The serotonergic system consists of a small number of neurons
that are born in the ventral regions of the hindbrain (Deneris and
Wyler, 2012). In the adult nervous system, serotonergic neurons
[5-HT (5-hydroxytryptamine) neurons] are located in the nine
raphe nuclei that are restricted to the basal plate of the mid-
brain, pons, and medulla (Dahlstrom and Fuxe, 1964). 5-HT
neurons located in the rostral raphe nuclei, such as the dorsal
raphe nucleus (DRN) and the median raphe nucleus (MRN), give
rise to the majority of the serotonergic ascending ﬁbers into the
forebrain including cerebral cortex, limbic system, and basal gan-
glia (Jacobs and Azmitia, 1992). The activity of the serotonergic
system is regulated via transmitter release from local interneurons
and/or afferents to the raphe nuclei (hetero-regulation), via mech-
anisms arising from 5-HT neurons themselves (auto-regulation),
and potentially via alterations in the extracellular milieu (e.g.,
increase in CO2; Pineyro and Blier, 1999; Richerson, 2004). In this
review, we will discuss G protein-coupled receptors (GPCRs) and
ion channels located at somatodendritic and presynaptic regions
of 5-HTneurons in theDRNandMRNthat contribute to themod-
ulation of 5-HT neuronal activity and 5-HT release (Figure 1).
The DRN and MRN are the primary nuclei of 5-HT projections
to forebrain and provide the neural substrate to communicate
between global forebrain and other neuromodulatory systems by
sending a wide range of 5-HT projections and receiving a wide
variety of afferents (Jacobs andAzmitia, 1992). TheDRN is located
right beneath the posterior part of cerebella aqueduct and con-
tains about half of all 5-HT neurons in the central nervous system
(CNS), which can be further divided into six regions: rostral, cau-
dal, dorsomedial, ventromedial, interfascicular, and lateral parts.
The MRN is located at the ventral expansion of the DRN or the
midline of the pontine tegmentum where many 5-HT neurons are
densely packed in the midline and some 5-HT neurons are scat-
tered in the periphery. Within the DRN and MRN 5-HT neurons
project to deﬁned target area in brain (Adell et al., 2002; Lechin
et al., 2006). For example, DRN 5-HT neurons innervate the pre-
frontal cortex, lateral septum, and ventral hippocampus, while
MRN 5-HT neurons innervate the temporal cortex, medial sep-
tum, and dorsal hippocampus. Afferent projections to the raphe
nuclei are diverse and include acetylcholine (ACh) from the lat-
erodorsal tegmental nucleus, dopamine from the substantia nigra
and ventral tegmentum area, histamine from tuberomammil-
lary hypothalamic nucleus, noradrenaline (NA) from the locus
coeruleus, serotonin itself from the raphe nuclei and several
neuropeptides as well as excitatory glutamatergic and inhibitory
GABAergic inputs. Glutamatergic inputs come from several nuclei
including medial prefrontal cortex and lateral habenula nucleus
(Aghajanian and Wang, 1977; Celada et al., 2001; Adell et al.,
2002; Bernard and Veh, 2012). Some inputs make direct contacts
with 5-HT neurons, while others project onto local GABAergic
interneurons that provide feedforward inhibitory input to 5-HT
neurons (Sharp et al., 2007). In addition to the local GABAergic
interneurons located in the raphe nuclei and in the neighboring
periaqueductal gray area, extrinsic GABAergic projections have
been suggested (Gervasoni et al., 2000). The responsiveness of 5-
HT neurons to each of the inputs differs between DRN and MRN,
and alsowithin the subnuclei of theDRN (Adell et al., 2002; Lechin
et al., 2006). The differences in responsiveness most likely depend
on differences in the strength of the afferent inputs for each of
the nuclei and subnuclei and also on the expression and types of
the ionotropic and metabotropic receptors in 5-HT neurons. Fur-
thermore, the intrinsic membrane excitability of 5-HT neurons
has been reported to differ in the distinct raphe nuclei (Beck et al.,
2004; Crawford et al., 2010). Importantly, beyond the anatomical
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and physiological differences, it has been reported that subpop-
ulation of 5-HT neurons have distinct implications in speciﬁc
physiological function and behavior (Abrams et al., 2004; Lechin
et al., 2006; Hale and Lowry, 2010).
AUTO-REGULATION
The midbrain 5-HT neurons elicit spontaneous action potentials
(APs), with a regular, slow ﬁring pattern (1–5 APs/s; Aghajanian
and Vandermaelen, 1982; Vandermaelen and Aghajanian, 1983).
5-HT released from 5-HT neurons act either on the 5-HT neu-
ron itself or on the target circuits. There are several ways how
5-HT neurons may receive 5-HT. First, dendrodendritic synapses
releasing 5-HT have been described in raphe nuclei between 5-HT
neurons. Second, recurrent axonal collaterals have been suggested
to back-propagate to the raphe nucleus itself to release 5-HT.
Finally, 5-HT neurons between different raphe nuclei such as
DRN and MRN communicate with each other via 5-HT (for
review, see Adell et al., 2002; Harsing, 2006; Lechin et al., 2006).
Indeed electrical stimulation in DRN slice preparations induces
5-HT1A receptor-mediated slow inhibitory postsynaptic poten-
tials (IPSPs) in 5-HT neurons (Pan et al., 1989; Morikawa et al.,
2000), demonstrating 5-HT release in the proximity of 5-HT
neurons.
Once 5-HT is released, 5-HT receptors will be activated. Seven
subgroups of 5-HT receptors encoding ionotropic as well as
metabotropic receptors have beendescribed (5-HT1–5-HT7),with
15 total variants identiﬁed to date (Barnes and Sharp, 1999; Hoyer
et al., 2002; Kroeze et al., 2002). The 5-HT GPCRs can be divided
into three major subgroups depending on which G protein sig-
naling pathway they activate. 5-HT1 receptors couple mainly to
the Gi/o pathway; 5-HT4, 5-HT5, 5-HT6, and 5-HT7 receptors
couple to the Gs pathway; and 5-HT2 receptors activate the Gq/11
pathway. The 5-HT3 receptors are ligand-gated ion channels.
5-HT1A, 5-HT1B, and 5-HT1D receptors are found on soma-
todendritic and axonal region of 5-HT neurons (McDevitt and
Neumaier, 2011). All three receptors act as negative feedback effec-
tors for 5-HT neuronal ﬁring and 5-HT release (Andrade, 1998).
Somatodendritically located 5-HT1A receptors down-regulate the
ﬁring rate of 5-HT neurons via activation of G protein-coupled
inwardly rectifying potassium channels (GIRK) leading to mem-
brane hyperpolarization, and reduction or complete block of
AP ﬁring (Colino and Halliwell, 1987; Sprouse and Aghajanian,
1987; Blier et al., 1989; Hjorth and Sharp, 1991; Penington et al.,
1993; Stamford et al., 2000). In addition, 5-HT1A receptors inhibit
voltage-gated Ca2+ channels of the N- and P/Q-type in 5-HT
neurons, as application of a selective 5-HT1A agonist dimin-
ishes somatic Ca2+ channel currents (Penington and Kelly, 1990;
Penington et al., 1992; Bayliss et al., 1997b). The functional conse-
quence of Ca2+ channel inhibition is an increase in the ﬁring rate
due to reduction in the afterhyperpolarization, which may involve
Ca2+ activated-K+ channel (Bayliss et al., 1997b). The physio-
logical role of the differential effects of 5-HT1A receptors on the
AP ﬁring has not been addressed so far, but may involve input
speciﬁcity due to 5-HT1A/GIRK and 5-HT1A/Ca2+ channel colo-
calization in speciﬁc subcellular domains and/or differences in the
regulatory properties of heterogeneous 5-HT neurons within and
among different raphe nuclei (Calizo et al., 2011).
The predominant 5-HT receptors at the presynaptic termi-
nal are the 5-HT1B/1D receptors. 5-HT1B/1D receptors have been
shown to inhibit 5-HT release from the axonal varicosities as
demonstratedwith electrophysiological experiments (Sprouse and
Aghajanian, 1987; Boeijinga and Boddeke, 1993; Morikawa et al.,
2000), probably due to inhibition of Ca2+ inﬂux through voltage-
gated Ca2+ channels such as P/Q-type and N-type Ca2+ channel
(Kimura et al., 1995; Harvey et al., 1996). The 5-HT1B receptors
have been shown to underlie presynaptic autoinhibition of 5-
HT release in which 5-HT1A-mediated slow IPSPs are reduced by
previous released 5-HT activating presynaptic 5-HT1B receptors
(Morikawa et al., 2000). In addition, 5-HT1B receptors have been
suggested to up-regulate 5-HT reuptake by serotonin transporters
(Xie et al., 2008; Hagan et al., 2012) and 5-HT synthesis by itself
might be under the control of 5-HT1B (Hjorth et al., 1995). Thus,
5-HT1B autoreceptors may have the ability to control 5-HT release
independently from the actual ﬁring rate.
5-HT1F receptor mRNA has also been detected in the raphe
nuclei (Bruinvels et al., 1994). Since 5-HT1F receptors have a
high afﬁnity for sumatriptan, a 5-HT1B/1D agonist, and the
sumatriptan-induced reduction in 5-HT release (monitored by
voltammetry in brain slices) could not be blocked by 5-HT1A/1B/1D
receptor antagonists, 5-HT1F had been suggested as a possible can-
didate of a serotonergic autoreceptor in the MRN (Hopwood and
Stamford, 2001).
While the expression and function of 5-HT1 receptors has been
directly demonstrated in 5-HT neurons, involvement of other 5-
HT receptors such as 5-HT2, 5-HT3, and 5-HT4−7 is less clear and
may differ among species, the developmental stage of the animal
and 5-HT neuron subtypes.
5-HT2 receptors are functionally expressed in particular on
GABAergic interneurons in the DRN, since activation of 5-
HT2A/2C receptors increase fast inhibitory postsynaptic current
(IPSC) frequency in 5-HT neurons and reduce 5-HT neuronal ﬁr-
ing as electrophysiologically measured in brain slices (Liu et al.,
2000; Leysen, 2004). 5-HT2 receptor mRNA and proteins have
been identiﬁed in the DRN and embryonic 5-HT neurons (Wright
et al., 1995; Clemett et al., 2000; Wylie et al., 2010). Additionally, 5-
HT2 receptors have been postulated to increase 5-HT1A-mediated
responses in 5-HT neurons (Kidd et al., 1991). However, a direct
modulatory effect of 5-HT2 in 5-HT neurons has not been
demonstrated.
The 5-HT3 receptors have also been suggested to act as presy-
naptic autoreceptors in serotonergic nerve terminals. Although
5-HT3 receptors have been shown to enhance 5-HT release in
various brain areas including the raphe nuclei as monitored
by [3H]5-HT assays (Bagdy et al., 1998), there is no direct
immunohistochemical and electrophysiological evidence of the
presence of 5-HT3 receptors in 5-HT neurons (van Hooft and
Vijverberg, 2000).
For the Gs protein-coupled 5-HT4−7 receptors,mainly indirect
evidence exists for an autoregulatory role of these GPCRs in 5-HT
neurons.
5-HT4 receptors seem to be located somatodendritically and
presynaptically. A presynaptic potentiating effect of 5-HT4 recep-
tor on glutamate release, which can be counteracted by 5-
HT1A receptor-mediated inhibitory action, has been described in
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FIGURE 1 | Intrinsic somatodendritic and presynaptic modulation of
action potential (AP) firing and transmitter release in 5-HT neurons. (A)
AP ﬁring of 5-HT neurons is modulated by GPCRs and ion channels. AP ﬁring
is reduced (red arrows) via activation of GPCRs coupling to the Gi/o pathway
or activation of inhibitory ligand-gated ion channels. Gi/o pathway activation
can lead to the activation of GIRK channels, inhibition of voltage-gated Ca2+
channels or increase in GABAA receptor currents. In addition, Gq/11 activation
can lead to synthesis of endocannabinoids, which inhibit transmitter release
onto 5-HT neurons. AP ﬁring is increased (blue arrows) via activation of
GPCRs coupling to the Gq/11 pathway or activation of excitatory ligand-gated
ion channels. Gq/11 pathway activation can lead to the activation of
non-selective cation channels or inhibition of K+ conductance. In addition, the
activation of L-type Ca2+ channels via protein kinase C (PKC) can most likely
increase membrane depolarization and transcription. (B) 5-HT release of 5-HT
neurons is also modulated by GPCRs and ion channels. 5-HT release is
reduced (red arrow) via activation of GPCRs coupling to the Gi/o pathway. Gi/o
pathway activation leads to the inhibition of presynaptic Ca2+ channels,
reduction in Ca2+ inﬂux and therefore reduction in transmitter release. 5-HT
release is increased (blue arrows) via activation of GPCRs coupling to the Gs
pathway and via opening of excitatory, ligand-gated ion channels.
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hippocampal neurons (Kobayashi et al., 2008). Since neurotrans-
mitter release of various transmitters including 5-HT ismodulated
by 5-HT4 agonists, a presynaptic localization of 5-HT4 receptors
on 5-HT neurons seems possible (Mengod et al., 2010).
While the function of 5-HT5 receptors in the CNS has not been
thoroughly studied, two studies suggest a role of 5-HT5 receptors
for modulating 5-HT neurons. First, 5-HT5B receptor mRNA, a
receptor which is expressed in rodents but not in humans, is colo-
calized with the mRNA of 5-HT transporter in the DRN (Serrats
et al., 2004). Second, block of 5-HT5A receptors in the DRN atten-
uates the 5-carboxamidotryptamine (5-CT; non-selective agonist
in particular for 5-HT1A/1B/1D receptors) induced reduction of 5-
HT neuronal ﬁring but fail to affect 5-HT release measured using
fast cyclic voltammetry in vitro (Thomas et al., 2006). The data
suggest an autoreceptor modulation of 5-HT neurons via 5-HT5A
receptors.
5-HT6 and 5-HT7 receptor protein and mRNA have been
detected in cells in the raphe nuclei including the DRN (Ruat
et al., 1993; To et al., 1995; Gustafson et al., 1996; Woolley et al.,
2004; see also Gerard et al., 1997; Hamon et al., 1999), but a func-
tional role as autoreceptors for modulating 5-HT neurons could
not be demonstrated so far (Bourson et al., 1998; Roberts et al.,
2001).
Thus, the auto-regulation of 5-HT neuronal ﬁring is in par-
ticular regulated by 5-HT1A receptors via activation of the Gi/o
pathway and opening K+ and closing Ca2+ conductance. At the
presynaptic terminal, 5-HT1B/1D receptor activation reduces 5-HT
release most likely via Gi/o protein-mediated inhibition of presy-
naptic Ca2+ channels. In addition, potentiation of 5-HT release
by activating 5-HT4 receptors via the Gs pathway seems possible.
Since other 5-HT receptor mRNAs have been detected in 5-HT
neurons, other autoregulatorymechanismsmay exist in subgroups
of 5-HT neurons or during different developmental stages of the
serotonergic transmitter system. In particular, animal models for
the selective activation of these GPCRs during development will
further elucidate the modulatory role of other 5-HT receptors in
the auto-regulation of 5-HT neuronal ﬁring and 5-HT release.
HETERO-REGULATION
5-HT modulates various complex behaviors and therefore the
serotonergic transmitter system receives feedback and feedforward
information from other brain areas and networks involved in reg-
ulating the different behaviors (Adell et al., 2002; Lechin et al.,
2006; Sharp et al., 2007). Thus, the hetero-regulation of the 5-HT
neurons involves various transmitter systems.
Forty-nine different GPCRs belonging to all four GPCR sub-
families were identiﬁed in postmitotic embryonic 5-HT neurons
using microarray expression proﬁling (Wylie et al., 2010). These
GPCRs include adrenergic, calcitonin, cannabinoid, GABA, his-
tamine, opioid, and serotonin receptors. For these transmitter
systems, a postnatal modulatory role for 5-HT neurons has been
described (see below). In addition, otherGPCRs such as thrombin,
chemokine, prostaglandin E, melanin-concentrating hormone,
cadherin, and parathyroid hormone receptors as well as frizzled
(FZD) and smoothened (SMO) homolog and the orphan recep-
tors (GPR 19, 56, 85, 98, 125 135, 162, and 173)were also identiﬁed
but a physiological role for their modulation of 5-HT neurons still
needs to be deﬁned and investigated (for a complete list, see Wylie
et al., 2010). We will summarize recent ﬁndings on the intrinsic
hetero-regulation of the serotonergic transmitter system.
GABA, GLYCINE, AND GLUTAMATE
5-HT neurons within the raphe nuclei receive in particular
GABAergic but also glutamatergic input. As expected, the
GABAergic input onto 5-HT neurons reduces the neuronal ﬁring,
while glutamatergic input increases the ﬁring activity (Pan and
Williams, 1989; Levine and Jacobs, 1992; Becquet et al., 1993a,b;
for review, see Adell et al., 2002; Harsing, 2006). These effects have
been mainly attributed to the expression of ionotropic GABA and
glutamate receptors (GluRs) in 5-HT neurons (Tao and Auerbach,
2000; Gartside et al., 2007), which is in agreement with the expres-
sion of 2-amino-3-(3-hydroxy-5-methyl-isoxazol-4-yl)propanoic
acid (AMPA), N-methyl-D-aspartate (NMDA), kainate receptors
[GluR 1,2; NMDA-R-2B, kainate receptor 5 (Grik5)] as well as
GABAA receptor subunits (GABAA β1–3 and γ2) in embryonic
5-HT neurons (Wylie et al., 2010). Interestingly, the glycine recep-
tor α1 and β subunits have also been identiﬁed in human brain
and mice embryonic 5-HT neurons (Baer et al., 2003; Wylie et al.,
2010). Indeed the DRN receives input from glycinergic ﬁbers
(Rampon et al., 1996, 1999) to inhibit 5-HT neuronal ﬁring and 5-
HT release (Gallager andAghajanian, 1976;Wang andAghajanian,
1977; Becquet et al., 1993a).
The modulation of 5-HT neurons by GABAB receptors has
been addressed in various studies. In general, activation of GABAB
receptor by selective agonists decreases 5-HT release (Becquet
et al., 1993b). The decrease of 5-HT release by GABAB receptors
located within 5-HT neurons is most likely mediated via activa-
tion of GIRK channels leading to a reduction in AP ﬁring (Innis
and Aghajanian, 1987; Williams et al., 1988; Bayliss et al., 1997a;
Cornelisse et al., 2007). Within 5-HT neurons, GABAB receptors
are located extrasynaptically, suggesting that spillover of GABA
during high activity of GABAergic neurons would modulate 5-
HT neuronal activity within raphe nuclei (Varga et al., 2002).
On the other hand, there is little information about modula-
tory effects of metabotropic GluRs (mGluRs) in 5-HT neurons
so far. Although administration of group II mGluR (mGluR2/3)
antagonist has been reported to increase 5-HT neuronal activity,
an indirect effect on presynaptic excitatory neurons seems to be
involved (Kawashima et al., 2005).
CORELEASE OF GLUTAMATE OR GABA FROM 5-HT NEURONS
Previous reports have suggested the possibility of glutamate release
from 5-HT neurons based on the presence of vesicular glutamate
transporter type 3 in a subset of 5-HT neurons (Gras et al., 2002;
Amilhon et al., 2010). Using optogenetic techniques, the core-
lease of glutamate and 5-HT from serotonergic terminals could
be demonstrated in a serotonergic projection from the MRN to
hippocampal GABAergic interneurons (Varga et al., 2009). The
serotonergic ﬁbers make direct synaptic contacts to the GABAer-
gic neurons and exert fast synaptic transmission mediated by
ionotropic GluRs and 5-HT3 receptors. In addition to the glu-
tamate transporters, GABA and its synthesizing enzyme, glutamic
acid decarboxylase (GAD) have also been reported in subsets
of 5-HT neurons, suggesting the corelease of GABA and 5-HT
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(Nanopoulos et al., 1982; Belin et al., 1983; Fu et al., 2010; Hioki
et al., 2010; Shikanai et al., 2012). However, vesicular inhibitory
amino acid transporter which is necessary for ﬁlling synaptic vesi-
cles with GABA was absent in 5-HT/GAD67 positive neurons and
their projections, suggesting that GABA may be released by non-
vesicular mechanisms such as a reverse transport through GABA
transporters (Shikanai et al., 2012). Thus, 5-HT axonal projections
have a potential to modulate the neuronal activity in target areas
using at least three different transmitters, i.e., 5-HT, glutamate,
and GABA. It is intriguing to speculate that the auto-regulation of
5-HT neurons itself might be modulated by corelease of glutamate
and GABA.
ACETYLCHOLINE
The DRN also receives cholinergic input from the laterodorsal
tegmental nucleus (Wang et al., 2000). Modulation of 5-HT neu-
rons by ACh mainly involves nicotinic ACh receptors (nAChRs)
and can increase 5-HT neuronal ﬁring (Mihailescu et al., 2002)
for example, via presynaptic modulation of glutamate release
(Garduno et al., 2012) or via opening of nAChR expressed in
5-HT neurons (Galindo-Charles et al., 2008; Chang et al., 2011).
Very limited information is available for the expression and func-
tion of muscarinic ACh receptors (mAChRs) in 5-HT neurons.
mAChR-M1 receptors (Gq/11) might be expressed on serotoner-
gic projections into the hippocampus (Rouse and Levey, 1996)
and application of mAChR antagonist, atropine into the DRN
enhances antidepressant-like 5-HT1A agonist effects (Haddjeri
et al., 2004), which may involve M2 (Gi/o) but not M1 (Gq/11)
receptors (Haddjeri et al., 2000). Nevertheless a detailed and direct
demonstration of the involvement of mAChRs in 5-HT neurons
is essential.
DOPAMINE
The 5-HT neurons of the DRN reciprocally interact with
the dopaminergic mesencephalic transmitter system involving
dopamine receptors. D1-like receptors (D1 and D5) couple to
the Gs pathway, while dopamine D2-like receptors (D2−4) have
been described to couple to the Gi/o pathway. In the DRN, D2
and D3 receptor expression has been detected so far, with very
little or no expression of D1-like receptors (Bouthenet et al., 1987;
Dawson et al., 1988; Cortes et al., 1989; Wamsley et al., 1989;
Yokoyama et al., 1994; Suzuki et al., 1998). Dopamine increases
5-HT neuronal ﬁring in DRN in vivo and in slice electrophysio-
logical recording, and also increases 5-HT release detected by in
vivo microdialysis in DRN and other brain areas (Ferre and Arti-
gas, 1993; Ferre et al., 1994; Matsumoto et al., 1996; Mendlin et al.,
1998; Haj-Dahmane, 2001; Martin-Ruiz et al., 2001). The modu-
latory effects on 5-HT neurons have been shown to be mediated by
D1- and D2-like receptors located outside the DRN (Martin-Ruiz
et al., 2001) or by direct activation of D2 receptors expressed in
5-HT neurons (Haj-Dahmane, 2001). Activation of D2-like recep-
tors in 5-HTneurons leads tomembrane depolarization, involving
activation of G proteins, phospholipase C, and a non-selective
cation current,most likely mediated by a transient receptor poten-
tial (TRP) channel (Aman et al., 2007). TheD2-like receptor effects
in 5-HT neurons suggest that D2-like receptors may activate the
Gq/11 rather than the Gi/o signaling pathway. The Gq/11 protein
coupling might be explained by the heterodimerization between
D1- and D2-like receptors (Rashid et al., 2007; Hasbi et al., 2010).
It has to be noted that the experiments suggesting the modula-
tion of 5-HT neurons by intrinsic D2-like receptors have been
performed with relatively high concentrations of quinpirole and
sulpiride in in vitro preparations. Therefore, the experiments have
to be interpreted carefully.
NORADRENALINE
5-HT neurons in the raphe nuclei receive noradrenergic input
in particular from the locus coeruleus (Adell et al., 2002; Lechin
et al., 2006). α1 and α2 adrenergic receptor mRNA and protein
have been detected in the DRN and MRN (Unnerstall et al., 1985;
Rosin et al., 1993; Scheinin et al., 1994; Talley et al., 1996; Day et al.,
1997; Strazielle et al., 1999). α1 and α2 adrenergic receptors couple
to the Gq/11 and Gi/o pathway, respectively. Therefore depending
on pathway activation, an increase or decrease in 5-HT neuronal
activity and 5-HT release can be postulated if adrenergic recep-
tors are expressed in 5-HT neurons. Early studies revealed that NA
causes an increase in 5-HT neuronal ﬁring in DRN. This effect
has been suggested to be mediated via activation of α1 adreno-
ceptors (presumably α1B adrenoceptor subtype) located on 5-HT
neurons (Vandermaelen and Aghajanian, 1983; Day et al., 1997)
and may involve the suppression of a 4-aminopyridine sensitive
K+ conductance (IA; Aghajanian, 1985). In vivo experiments sug-
gest that α1 adrenoceptors are tonically activated by endogenous
NA (Adell and Artigas, 1999; Pudovkina et al., 2003). In con-
trast, 5-HT release detected by voltammetry or [3H]5-HT assay
in the DRN slice preparation is inhibited by NA, an effect which
has been attributed to α2 adrenoceptors (involving α2A adreno-
ceptor subtype) and also perhaps indirectly to α1 adrenoceptors
(Frankhuijzen et al., 1988; Hopwood and Stamford, 2001). Since
α2 receptors couple to the Gi/o pathway, 5-HT release and 5-HT
neuronal ﬁring could be reduced via α2 adrenoceptors located at
the soma or presynaptic terminal of 5-HT neurons itself (Hop-
wood and Stamford, 2001), or via inhibition of NA release at
noradrenergic synaptic terminals lowering the effective NA con-
centration for α1 adrenoceptors/Gq signaling pathway activation.
The direct effect of α2 adrenoceptors in 5-HT neurons is sup-
ported by the fact that embryonic 5-HT neurons express α2A
adrenoceptors (Wylie et al., 2010).
HISTAMINE
There are four histamine receptors (H1−4), which couple to dif-
ferent G protein pathways, i.e., H1 (Gq/11), H2 (Gs), H3, and H4
(Gi/o). Early studies suggested that histamine reduces the ﬁring
of 5-HT neurons in the DRN (Lakoski and Aghajanian, 1983)
via H2 receptors (Lakoski et al., 1984). Since H2 couples to the
Gq/11 pathway, the results suggest that H2 receptors are localized
on GABAergic terminals. Later ﬁndings showed that histamine
increased 5-HT neuronal ﬁring in the DRN via activation of H1
receptors and the opening of a non-selective cation conductance
through Gq/11 signaling pathways (Barbara et al., 2002; Brown
et al., 2002). Expression proﬁling in mouse embryos suggested
the expression of H3 receptors in 5-HT neurons, which is consis-
tent with high mRNA levels in the DRN (Lovenberg et al., 1999;
Drutel et al., 2001; Pillot et al., 2002). However, the low binding
Frontiers in Integrative Neuroscience www.frontiersin.org May 2013 | Volume 7 | Article 40 | 5
“fnint-07-00040” — 2013/5/21 — 14:57 — page 6 — #6
Maejima et al. Modulation of 5-HT neurons
of a H3 receptor selective radioligand in the DRN suggests that
H3 receptors are mainly functional at the presynaptic terminal
of 5-HT projections (Pillot et al., 2002). Indeed increasing lev-
els of histamine decrease 5-HT release detected by an in vivo
electrochemical technique (Hashemi et al., 2011).
ENDOCANNABINOIDS
The cannabinoid receptor family consists of two subtypes,CB1 and
CB2. Modulation of neuronal activity is mainly exerted via CB1,
which couples to the Gi/o protein (Howlett et al., 1986) and proba-
bly also to the Gs pathway (Glass and Felder, 1997). CB1 receptors
are localized in particular at presynaptic terminals, where they
inhibit presynaptic Ca2+ inﬂux and reduce transmitter release via
endocannabinoid (eCB)-mediated retrograde signaling (Maejima
et al., 2001). CB1 receptors are expressed in serotonergic ﬁbers
(Haring et al., 2007; Ferreira et al., 2012) and their mRNA is found
early in development (Wylie et al., 2010). 5-HT release in pro-
jection areas from the DRN is reduced by activation of CB1 as
monitored by microdialysis (Egashira et al., 2002) and [3H]5-HT
assay (Nakazi et al., 2000; Egashira et al., 2002), and increased by
inhibition of CB1 in vivo and in vitro (Darmani et al., 2003; Tzavara
et al., 2003; Aso et al., 2009). Studies in CB1 knock-out animals
and chronic activation of CB1 receptors in vivo suggest that CB1
may regulate the function and expression of 5-HT1A receptors
(Aso et al., 2009; Moranta et al., 2009; Zavitsanou et al., 2010).
Interestingly, 5-HT neurons itself synthesize eCBs in an activity-
dependent manner (Haj-Dahmane and Shen, 2009, 2011). eCB
release from 5-HT neurons can be induced by orexin-B leading
to the activation of orexin (OX) receptors via the Gq/11 pathway
(Liu et al., 2002b; Haj-Dahmane and Shen, 2005). It has been
therefore speculated that the activity-dependent activation of the
Gq/11 pathway in general may lead to the production of eCBs in
5-HT neurons (Haj-Dahmane and Shen, 2011). Within the DRN
eCBs mainly act on glutamatergic terminals and probably also on
GABAergic terminals (Liu et al., 2002b; Haj-Dahmane and Shen,
2009; Mendiguren and Pineda, 2009; Tao and Ma, 2012), lead-
ing to a reduction in glutamate and GABA release onto 5-HT
neurons and therefore changes the activity of the 5-HT neurons
itself.
FRIZZLED RECEPTORS
Four frizzled receptors (FZD1–3 and SMO) have been detected in
postmitotic embryonic 5-HT neurons (Wylie et al., 2010). These
receptors mainly couple to the Wnt signaling cascade and are
most likely involved in the development and maturation of 5-
HT neurons (Simon et al., 2005; Song et al., 2012). However,
the role of frizzled receptors in 5-HT neurons remains to be
determined.
NEUROPEPTIDES
Dr. Hökfelt’s laboratory demonstrated that various peptide trans-
mitters are expressed in the DRN with species-speciﬁc differences
between mice and rats (Fu et al., 2010). The identiﬁed neu-
ropeptides are cholecystokinin (CCK), calcitonin gene-related
peptide (CGRP), vasoactive intestinal peptide (VIP), somato-
statin, substance P, dynorphin, neurotensin, thyrotropin-releasing
hormone (TRH), enkephalin, galanin, neuropeptide Y (NPY),
and corticotropin-releasing factor (CRF). Among these, various
peptide receptors have been identiﬁed and functionally described
in 5-HT neurons.
BOMBESIN
To date three types of bombesin receptors have been described,
i.e., the neuromedinB (NMB) receptor (BB1 receptor), the gastrin-
releasing peptide (GRP) receptor (BB2 receptor) and the bombesin
receptor subtype 3 (BRS-3orBB3 receptor; Jensen et al., 2008). The
NMB receptors are functionally expressed in 5-HT neurons in the
DRN (Pinnock et al., 1994; Woodruff et al., 1996). BB1 receptor
activation leads to an increase in 5-HT neuronal ﬁring via sup-
pression of K+ current, involving most likely the activation of the
Gq/11 pathway (Benya et al., 1992; Woodruff et al., 1996) and as a
consequence, an increase in 5-HT release to projection site such
as the hippocampus, which is monitored by in vivo microdialysis
(Merali et al., 2006).
CALCITONIN
Calcitonin receptor (CalcR) mRNA has been localized in 5-HT
neurons in theDRN(Nakamoto et al.,2000),which is in agreement
with the expression proﬁling studies of postmitotic embryonic 5-
HT neurons (Wylie et al., 2010). The CalcR couples to the Gs
pathway (Hay et al., 2005) and Gq/11 pathway (Offermanns et al.,
1996). Since high levels of amylin binding sites are detected in
the DRN (Sexton et al., 1994) and mRNA for CGRP has been
localized in 5-HT positive axon terminals in monkeys (Arvidsson
et al., 1990), it is most likely that CalcR assemble with receptor
activity-modifying proteins (RAMPs) in 5-HTneurons to respond
to the various peptide transmitters (i.e., CGRP, adrenomedullin,
and amylin; Tilakaratne et al., 2000). A direct function of CalcR in
5-HT neurons has not yet been demonstrated. However, injection
of CGRP into rats induces anxiety-like behaviors and increases
c-Fos expression in the DRN (Sink et al., 2011).
CHEMOKINE RECEPTORS
Two subtypes of the 18 identiﬁed chemokine receptors have been
detected in microarray analyses from embryonic 5-HT neurons,
i.e., Duffy antigen/chemokine (C-X-C motif) receptor 4 (CXCR4;
Wylie et al., 2010). CXCR4 is expressed in the majority of 5-
HT neuron outer membranes in the DRN (Heinisch and Kirby,
2010). So far only an indirect action of CXCR4 for modula-
tion of 5-HT neuron has been demonstrated, since application
of the CXCR4 ligands and antagonists modulate GABA and glu-
tamate release onto 5-HT neurons (Heinisch and Kirby, 2010),
which is in agreement with the described Gi/o protein-mediated
inhibition of Ca2+ channels via CXCR4 (Oh et al., 2002). In addi-
tion, CX3CR1 is also expressed in 5-HT neurons in the DRN
and MRN (Heinisch and Kirby, 2009). Here the CX3CR1 spe-
ciﬁc ligand, fractalkine/CX3CL1 increased evoked IPSC amplitude
on 5-HT neurons (Heinisch and Kirby, 2009), an effect which
is most likely mediated postsynaptically and not presynaptically.
The effect is surprising, since CX3CR1 has been described to cou-
ple to the Gi/o pathway (Oh et al., 2002), which would inhibit
synaptic transmitter release and induce paired-pulse facilitation
(PPF) if activatedonGABAergic terminals. Therefore, theCX3CL1
could increase/modulate GABAA receptor trafﬁcking and GABAA
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receptor currents in 5-HT neurons via activation of CX3CR1. A
signaling function for Duffy antigen remains to be determined.
CHOLECYSTOKININ
The expression of CCK receptors in 5-HT neurons in the DRN has
also been suggested. Application of CCK increases 5-HT neuronal
ﬁring, which is blocked by the CCK1 antagonist L-364,718 (Boden
et al., 1991). In addition, 5-HT release measured as outﬂow of
[3H]5-HT in cortical slices is increased by CCK-4, which involves
CCK2 receptors (Siniscalchi et al., 2001). Both CCK1 and CCK2
receptors mainly couple to the Gq/11 and Gs pathway (de Weerth
et al., 1993; Lee et al., 1993; Ulrich et al., 1993).
CORTICOTROPIN-RELEASING FACTOR
Two CRF (CRF1 and CRF2) receptor subtypes have been described
in brain and both seem to be localized in GABAergic neurons in
the DRN as well as in 5-HT and non-5-HT neurons with differen-
tial subcellular localizations (for review, seeValentino et al., 2010).
CRF1 and CRF2 couple to the Gs pathway (Chang et al., 1993; Per-
rin et al., 1993; Vita et al., 1993; Lovenberg et al., 1995; Liaw et al.,
1996) and also the Gq/11 pathway in heterologous expression sys-
tems (Dautzenberg et al., 2004), leading to the assumption that
stimulation of CRF1 or CRF2 will increase neuronal ﬁring. Indeed,
activation of CRF1 on GABAergic neurons increases GABA release
onto 5-HTneurons,while activation of CRF2 elicits an inward cur-
rent in 5-HT neurons (Kirby et al., 2008). Based on the differential
localization of the CRF receptors within the DRN and its receptor
type-speciﬁc action on 5-HT neurons, it has been suggested that
at low concentrations of CRF, 5-HT neuronal activity is decreased,
while at high concentrations, 5-HT neuronal activity is increased
(Kirby et al., 2008; Valentino et al., 2010).
GALANIN
The neuropeptide galanin activates three types of galanin recep-
tors (GalR1−3). GalR1 and GalR2 are highly expressed in the DRN
(Melander et al., 1988; Larm et al., 2003; Lu et al., 2005; Sharkey
et al., 2008). Moreover, GalR1 expression has also been described
in 5-HT neurons from rats but not in mice (Xu et al., 1998; Larm
et al., 2003). GalR activation in theDRN causes a K+ conductance-
mediated hyperpolarization in rat brain slices (Xu et al., 1998),
most likely via GalR3-mediated Gi/o activation of GIRK channels
(Swanson et al., 2005). These effects are in agreement with in vivo
microdialysis studies showing that injection of galanin into the
DRNreduces 5-HT release viaGalR activation in the hippocampus
(Kehr et al., 2002). In contrast to the inhibitory actionof galaninon
5-HT neuronal activity, a reduction in inhibitory input onto 5-HT
neurons has also been described (Sharkey et al., 2008). Here, the
pan GalR1−3 agonist reduced GABA-mediated fast synaptic trans-
mission accompanied by increase of PPF, suggesting that GalRs are
expressed on GABAergic terminals and inhibit presynaptic Ca2+
channels via the Gi/o pathway. On the other hand, GalR2 agonist,
galanin (2–11) reduced IPSP amplitude but did not cause PPF, sug-
gesting a postsynaptic action (Branchek et al., 2000; Sharkey et al.,
2008). Additionally, galanin (2–11) was demonstrated to increase
5-HT release in hippocampal tissue by immunoﬂuorescence and
high-performance liquid chromatography (HPLC) measurement
(Mazarati et al., 2005). Therefore GalR2 receptors may activate 5-
HTneurons via reduction inGABAergic input onto 5-HTneurons
and/or via Gq/11-mediated increase in 5-HT neuronal ﬁring.
Galanin also modulates 5-HT1A autoreceptor responses in vivo. A
possible mechanism of this modulation could be the heterodimer-
ization of GalR with 5-HT1A which has been observed in het-
erologous expression systems (for review, see Kuteeva et al., 2008;
Borroto-Escuela et al., 2010).
HYPOCRETIN–OREXIN
The twohypocretin/orexin (OX1andOX2) receptors are expressed
in tryptophan hydroxylase-positive neurons in the DRN (Brown
et al., 2002). Their intracellular signaling targets are rather com-
plex involving activation of Gi/o, Gq/11, Gs , and other G proteins
(Scammell andWinrow, 2010). Orexin positive ﬁbers project onto
GABAergic as well as 5-HT neurons in the DRN (Peyron et al.,
1998). Application of the neuropeptides orexin-A and orexin-B
causes a Na+/K+ non-selective cation current in 5-HT neurons
(Brown et al., 2002; Liu et al., 2002b; Kohlmeier et al., 2008), sug-
gesting that activation of OX1 and OX2 leads to the increase
of 5-HT neuronal ﬁring. The neuropeptides also induce GABA
release onto 5-HT neurons at higher peptide concentrations (Liu
et al., 2002b). In addition, orexin increases the somatic L-type
Ca2+ current in 5-HT neurons in a protein kinase C-dependent
manner (Kohlmeier et al., 2008). It has therefore been suggested
that modulation of Ca2+ transients by orexin may be involved in
the transcriptional regulation of long-term processes (Kohlmeier
et al., 2008).
OPIOIDS
Raphe nuclei receive dynorphinergic, enkephalinergic, and β-
endophinergic innervation (Adell et al., 2002). These transmitters
activate μ, κ and δ opioid receptors, which primarily couple to
the Gi/o pathway. Injection of morphine into the DRN causes
an increase in 5-HT release detected in forebrain microdialysis
(Tao and Auerbach, 1994). The increase in 5-HT release is most
likely mediated via Gi/o protein-mediated inhibition of GABAer-
gic interneurons in the DRN, involving μ opioid receptors located
on GABAergic neurons (Jolas and Aghajanian, 1997). The mod-
ulation of 5-HT release in the DRN by κ and δ opioid receptors
has also been described (Tao and Auerbach, 2002). Activation of
δ receptors increased, while activation of κ receptors decreased 5-
HT release measured with in vivo microdialysis. The κ receptors
effects do not involve the modulation of GABAergic or gluta-
matergic inputs in the DRN (Tao and Auerbach, 2002), suggesting
that κ receptors are expressed in 5-HT neurons. Likewise, opi-
oid receptor-like1 (Oprl1) are most likely located and expressed
in 5-HT neurons as follows. Oprl1 or nociceptin (NOP) recep-
tors belong to the opioid receptor family but are activated by
NOP (orphanin FQ), a neuropeptide derived from prepronoci-
ceptin protein. High levels of NOP receptor binding sites have
been detected in the DRN (Florin et al., 2000) and Oprl1 recep-
tor expression could be detected in embryonic 5-HT neurons
(Wylie et al., 2010). NOP/orphanin FQ inhibits 5-HT release in
the DRN via Oprl1 (Tao et al., 2007), suggesting a functional role
of Oprl1 in 5-HT neurons early in development and in the adult
brain.
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SUBSTANCE P
Substance P belongs to the tachykinin family and has a high
afﬁnity for the three different neurokinin receptors (NK1−3),
in particular to NK1 (Hokfelt et al., 2001). These GPCRs cou-
ple mainly to the Gq/11 pathway (Stratowa et al., 1995), but
Gs pathway activation has also been reported for NK1 in cell
culture systems (Martini et al., 2002). Various histological stud-
ies have revealed extensive expression of NK1 receptors in the
DRN (Maeno et al., 1993; Saffroy et al., 1994; Vigna et al., 1994;
Charara and Parent, 1998; Sergeyev et al., 1999; Froger et al.,
2001). Most studies suggest that NK1 receptors are not local-
ized on 5-HT neurons (Froger et al., 2001; Santarelli et al., 2001),
while others revealed NK1 receptor expression in a subpopu-
lation of 5-HT neurons (Santarelli et al., 2001; Lacoste et al.,
2006, 2009). Interestingly, NK1 receptors are found in the cyto-
plasm of the 5-HT neurons and in dendritic membranes of
GABAergic neurons. After administration of NK1 antagonist or
deafferentation of substance P releasing projections, the density
of membrane bound NK1 receptors is increased in the soma-
todendritic region of 5-HT neurons, suggesting that membrane
trafﬁcking of NK1 receptors may be regulated by Substance
P input. This mechanism may contribute to the modulation
of 5-HT neuronal ﬁring under certain physiological conditions
(Lacoste et al., 2009). In addition, controversial results exist for
the effect of NK1 on 5-HT release and ﬁring of 5-HT neurons.
Inhibition of NK1 in the DRN using antagonists or knock-out
strategies leads to an increase in ﬁring activity of 5-HT neu-
rons in vivo (Haddjeri and Blier, 2001; Santarelli et al., 2001).
In contrast, activation of NK1 and NK3 increases spontaneous
excitatory postsynaptic currents (EPSCs) in DRN 5-HT neu-
rons resulting in an increased ﬁring of the 5-HT neurons as
observed in brain slice recording (Liu et al., 2002a). These effects
could be blocked by NK1 and NK3 antagonists (Liu et al., 2002a).
Also, activation of NK1 via intra-raphe injection of substance
P in the DRN increases 5-HT release within the DRN, but
decreases 5-HT release in frontal cortex as measured with in
vivo microdialysis (Guiard et al., 2007). These effects and also
the described increase in 5-HT ﬁring in NK1 knock-out mice
involve changes in 5-HT1A autoreceptor levels, suggesting at least
a functional coupling between NK1 and 5-HT1A receptors. Fur-
ther investigations to verify these interactions in 5-HT neurons are
required.
In summary, the various heteroreceptors integrate incoming
information via two main pathways, i.e., Gi/o and Gq/11 lead-
ing to inhibition or activation of 5-HT neuronal ﬁring and 5-HT
release, respectively. Besides the “classical” Gi/o protein-mediated,
membrane-delimited modulation of GIRK and presynaptic Ca2+
channels, other ion channel targets have been identiﬁed in 5-HT
neurons. For example, two-pore-domain K+ channels [TWIK-
related acid-sensitive K-1 (TASK-1) and TASK-3] have been
described in dorsal and caudal raphe 5-HT neurons (Washburn
et al., 2002). TASK channels are inhibited by GPCRs coupling to
the Gq/11 pathway most likely in a membrane-delimited man-
ner involving the direct binding of Gαq subunits (Chen et al.,
2006). The existence of voltage-sensitive but not ATP-dependent
K+ channels in DRN neurons including 5-HT neurons have been
proposed based on drug application studies (Harsing, 2006). In
addition, TRP channels have been described to be modulated by
D2-like receptors (Aman et al., 2007). According to the microar-
ray expression proﬁling studies, various ion channel targets of
GPCRs are expressed in embryonic 5-HT neurons including
TRP (Trpm4 and Trpm7), two-pore channels (TPCN1), cyclic
nucleotide gate channels (Hcn3), and KCNQ (Kcnq2; Wylie et al.,
2010). Therefore, more detailed studies have to be performed to
determine the role of other ion channel targets and in particu-
lar long-term effects of GPCR modulation for the serotonergic
system.
INTEGRATION AND SIGNAL PROCESSING OF MODULATORY
INFORMATION BY SEROTONERGIC NEURONS: WHY SO
MANY GPCRs?
The serotonergic transmitter system modulates many physiologi-
cal functions such as mood, sexual behavior, feeding, sleep/wake
cycle, memory, cognition, blood pressure regulation, breath-
ing, and reproductive success (Mooney et al., 1998; Abrams et al.,
2004; Lechin et al., 2006; Lerch-Haner et al., 2008; McDevitt and
Neumaier, 2011). Because of the complexity and variety of the
different behaviors modulated by serotonin, it is expected that
modulatory signals from other brain areas including sensory
information is integrated by GPCR signals in nuclei containing
5-HT neurons using a high diversity of GPCRs. While GABA
and glutamatergic input into the raphe nuclei will adjust 5-
HT neurons to the current inhibitory/excitatory state of the
brain, other transmitter systems will inform 5-HT neurons more
directly about the serotonin-associated behavior. For example,
dopamine is involved in reward-driven learning; ACh modu-
lates arousal and reward; NA and CRF are involved in stress
responses; histamine is involved in sleep regulation and sexual
function; bombesin and CCK regulate eating behavior; eCBs
modulate memory, appetite, stress, social behavior, anxiety, and
sleep; galanin has been implicated in the regulation of sleep–wake
cycle, cognition, emotion, and blood pressure; hypocretin–orexin
modulate arousal, wakefulness, and appetite; and opioids and
substance P are involved in pain perception and mood (White
and Rumbold, 1988; Woodruff et al., 1996; Greenough et al., 1998;
Bear et al., 2001; Merali et al., 2006; Monti, 2010; Haj-Dahmane
and Shen, 2011). Since all different behavioral responses can be
integrated in nuclei containing 5-HT neurons, regulation of sero-
tonin release will affect similar behaviors as stated above. Thus
there is a tight interaction and signaling exchange between the
different transmitter systems to preciselymodulate behavioral out-
put. Consequently, long-term changes in serotonin release can
involve changes in the auto-regulation involving 5-HT receptor
or hetero-regulation involving the above mentioned GPCRs and
can cause neuropsychiatric disorders, most notably depression,
anxiety, schizophrenia, and dementia (Lucki, 1998; Davidson
et al., 2000; Mann et al., 2001; Nelson and Chiavegatto, 2001).
The modulation of the different behaviors is even more com-
plex since other GPCRs, such as orphan GPCRs, with so far
unknown function are also expressed in 5-HT neurons. Therefore,
new strategies and techniques have to be applied and devel-
oped to understand complex behaviors related to the serotonergic
system.
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NEW APPROACHES TO CONTROL AND UNDERSTAND
SEROTONERGIC G PROTEIN-COUPLED RECEPTOR
SIGNALING PATHWAYS
Recently, several new approaches to manipulate the activity of
5-HT neurons in a cell type-speciﬁc manner have been devel-
oped. Various promoter/enhancer sequences have been isolated
and characterized, which allow for the expression of proteins
of choice within at least subsets of 5-HT neurons. These DNA
sequences include the promoter or enhancer sequences of Pet-
1/Fev transcription factor, the serotonin transporter (SLC6A4),
and the tryptophan hydroxylase 2 (TPH2; Scott et al., 2005).
Using these different promoter/enhancer sequences, different
mouse lines and virus approaches have been developed to acti-
vate and/or silence/delete reporter genes such as green ﬂuorescent
protein (GFP) or tdTomato, Cre or Flip recombinases, tetracy-
cline inducible systems, tetanus toxin light chain, and genes of
interest (Scott et al., 2005; Kim et al., 2009; Madisen et al., 2010,
2012; Richardson-Jones et al., 2010; Zhao et al., 2011). Using the
tetracycline inducible system, for example, the genetic ablation of
5-HT1A from the majority of 5-HT neurons could be achieved
(Richardson-Jones et al., 2010, 2011).
For the investigation of the modulation and function of neu-
ronal circuits in general and for the serotonergic system in
particular, chemical and optogenetic techniques have been devel-
oped in recent years (Herlitze and Landmesser, 2007; Masseck
et al., 2010). For control of neuronal activity in various neuronal
circuits including the 5-HT system, the light-gated non-selective
cation channel, ChR2 has been used and allows for the dissection
of 5-HT-mediated behavioral effects in different raphe nuclei (Li
et al., 2005;Varga et al., 2009; Zhao et al., 2011;Madisen et al., 2012;
see also Kim et al., 2009). For the investigation of GPCR signals,
various chemically and light-activated GPCRs have been devel-
oped (Masseck et al., 2010). For example vertebrate rhodopsin
(vRh) has been used to regulate Gi/o signaling pathways in neu-
rons by light (Li et al., 2005). Exogenously expressed vRh inhibits
neuronal ﬁring and neurotransmitter release in vitro and in vivo
most likely via activation of GIRK and inhibition of presynap-
tic Ca2+ channels (Li et al., 2005; Oh et al., 2010; Gutierrez et al.,
2011). Since vRh belongs to class A or rhodopsin like group of
GPCRs, like serotonergic autoreceptors 5-HT1A/1B/1D, the idea
arose to generate light-activated chimeric receptors which couple
to intracellular signaling pathways in 5-HT1 receptor domains.
The feasibility of receptor domain swapping has been demon-
strated by Dr. Khorana’s group (Kim et al., 2005). They replaced
the intracellular loops of vRh with that of the β2-adrenergic recep-
tor and turned vRh into a light-activated Gs protein-coupled
receptor, Opto-β2AR. The approach however was not suitable
for the exchange of vRh intracellular peptide loops by the 5-
HT1A intracellular receptor domains, since this chimeric receptor
revealed altered activation and deactivation kinetics in respect to
GIRK channel modulation (Oh et al., 2010). However, it could
be shown that the C-terminus (CT) of the 5-HT1A receptor was
sufﬁcient to target vRh into expression domains of 5-HT1A recep-
tor and functionally substitute for Gi/o pathway activation. The
CTs of GPCRs contain peptide signal domains for subcellular
targeting and G protein interaction. The CT of 5-HT1A had
been shown to be necessary for trafﬁcking of the receptor to
dendritic domains via interaction with trafﬁcking protein Yif1B
(Carrel et al., 2008). Fusion of the 5-HT1A receptor CT onto
vRh was therefore sufﬁcient to target the chimeric construct Rh-
CT5-HT1A into somatodendritic regions of hippocampal neurons
and 5-HT neurons in the DRN and exclude the expression of
the chimeric receptor from the axons. The Rh-CT5-HT1A receptors
were able to functionally substitute for intracellular 5-HT1A signals
in DRN neurons of 5-HT1A knock-out mice, i.e., light illumi-
nation induced K+ conductance (most likely GIRK) reduced the
ﬁring rate of spontaneously active 5-HTneurons. Thus, the adjust-
ment of for example light-activated or chemically activatedGPCRs
and their coupling and anchoring to and in intracellular signaling
domains will allow for the dissection of multiple GPCR pathways
within the serotonergic system and their interaction in vitro and
in vivo.
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